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Endothelial dysfunction tends to be the initial indicator in proinflammatory state and macro- and microvascular complications,
such as atherosclerosis and cardiovascular diseases. It has been shown that certain compounds in diet can generate beneficial
effects on cardiovascular disease due to its interactions with endothelial cells. Thus, this review is aimed at investigating whether
certain polyphenols present in the Mediterranean diet, specifically catechin, quercetin, resveratrol, and urolithin, could exert
positive effects on endothelial dysfunction. After analysis of numerous papers, we found that polyphenols aiding endothelial
function is beneficial not only for patients with cardiovascular disease, diabetes, or endothelial dysfunction but for all people as
it can improve the effects of aging on the endothelia. The additional benefit of these polyphenols on weight loss further
improves health and lowers the risk of several diseases, including those caused by endothelial dysfunction. However, it is
important to note that the dosages in the majorities of the studies mentioned in this review were of supplemental rather than
nutritionally relevant quantities, and therefore, the recommended dosages are difficult to determine.
1. Introduction
1.1. Endothelial Function. Vascular endothelial cells line the
entire circulatory system, from the heart to the smallest cap-
illaries, and play a crucial role in maintaining cardiovascular
homeostasis, attenuating vascular inflammation and control-
ling blood flow and vascular tone [1, 2].
A shift in the functions of the endothelium can cause dys-
function through vasoconstriction, proinflammatory and
prothrombic states [2, 3]. Endothelial dysfunction tends to
be the initial state in macrovascular complications such as
coronary artery disease, peripheral arterial disease, and
stroke. It may also lead to microvascular complications such
as nephropathy, neuropathy, and retinopathy. Numerous
strategies have been developed to protect endothelial cells,
of which the role of polyphenolic compounds in modulating
the differentially regulated pathways has been proven to be
beneficial [4]. Control of the endothelial functions is
achieved through the production and release of various
mediators, such as the vasoconstrictor endothelin-1 (ET-1)
and relaxant nitric oxide (NO) that modify the responsive-
ness of the underlying vascular smooth muscle [3, 5] (see
Figure 1) [6].
The figure shows the different local factors that directly
affect the function of endothelial cells. Vasodilators and vaso-
constrictor modify the caliber of blood vessels. Coagulating
and anticoagulating factors permit an optimal control of
the hemostasis and impede spontaneous coagulations, which
are also influenced by inflammatory mediators. Together
with angiogenic factors and proliferation regulation, optimal
cell replacement and reparation are achieved. Generally, anti-
inflammatory mediators and dilating, proliferation, angio-
genic, and procoagulant factors tend to be beneficial for
diseases related to the cardiovascular system. However, these
should exist in a balanced state with their opposing factor/-
mediator to ensure correct endothelial function.
1.2. Polyphenols. Polyphenols are chemical compounds
synthesized by plants containing at least one aromatic ring
and a hydroxyl group [7]. They are the main source of
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antioxidants in diet, as they are abundant in plants, including
fruits, nuts, vegetables, and cereals, as well as derived bever-
ages such as tea, coffee, and wine [8]. There are more than
8000 known polyphenols, which are classified into phenolic
acids, stilbenes, phenolic alcohols, lignans, and flavonoids
[8, 9]. Polyphenols have spiked great interest in the scientific
community due to their health benefits, particularly in rela-
tion to cardiovascular diseases [10]. These exerted effects
are suggested to include anti-inflammatory, antithrombotic,
anticoagulant, antimicrobial, vasodilatory, and anticarcino-
genic protection [10].
1.3. Mediterranean Diet. The Mediterranean diet is widely
known for being rich in fruits, vegetables, legumes, nuts,
and grains with a moderate intake of red wine and reduced
consumptions of meat and dairy. Due to the antioxidant
and anti-inflammatory properties of plant foods and the
low intake of saturated fats, those following a Mediterranean
diet have been shown to have lower incidence of obesity,
insulin resistance, endothelial dysfunction, and cardiovascu-
lar disease [11, 12].
Red wine is one of the components present in this diet
and is thought to be responsible for the “French-paradox”,
which describes the low risk of cardiovascular disease despite
a diet rich in saturated fats and cholesterol [13]. Red wine
contains, among other compounds, quercetin, catechin, res-
veratrol, and ellagic acid; the latter of which urolithin is
obtained. Other fruits such as cherries, strawberries, grapes,
and apples also contain catechin, quercetin, and ellagic acid.
Additionally, vegetables such as onions, cabbage, cauliflower,
and capers contain important levels of quercetin. Walnuts
and peanuts present both resveratrol and ellagic acid. All
these compounds make up important components of the
Mediterranean diet, and therefore, in this paper, we review
the influence of these four polyphenols on overall health,
mainly focusing on their effects on endothelial function and
cardiovascular health.
1.4. Aging.Out of the theories of aging, those related to endo-
thelial dysfunction include the theory of free radicals, mito-
chondrial dysfunction, the role of the insulin pathway,
telomeric attrition, and senescence [14].
The idea of cellular senescence contributing to the aging
process is supported by the finding that senescent cells halt
normal function, irreversibly cease dividing, and accumulate
in aging organisms, thereby causing dysfunction through
inflammation and atherosclerotic plaques [15]. Endothelial
cell senescence is induced by multiple factors, such as oxida-
tive stress, vascular inflammation, and dysregulation of the
cell cycle, which causes structural and functional changes,
such as increased permeability of the endothelium, alter-
ations in mitochondrial biogenesis, impairment of vascular
repair, and angiogenesis [16]. Another hallmark of aging is
telomere attrition. In human aortic endothelial cells, the
inhibition of telomere function induces the expression of
ICAM-1 and reduces eNOS expression, indicating that endo-
thelial function is impaired in aging and cellular senescence











































Figure 1: Endothelial function mediators [6], modified from Sena 2018.
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been shown to have mediating effects on both ICAM-1 and
eNOS expressions, indicating that they might have the ability
to slow the shortening of telomeres caused by aging.
The IIS pathway is the most conserved aging-controlling
pathway in evolution, and among its multiple targets are the
FOXO family of transcription factors and the mTOR
complexes. The two nutrient sensors, AMPK and sirtuins,
act in the opposite direction to IIS and mTOR, and their
upregulation favor healthy aging [14]. Mitochondrial func-
tion becomes perturbed by aging-associated mtDNA muta-
tions, and defective mitochondrial function generates ROS
that, below a certain threshold, induce survival signals to
restore cellular homeostasis, but at higher or continued levels
contribute to aging [14]. There is compelling evidence that
polyphenols such as catechin, quercetin, and resveratrol
inhibit mitochondrial ATP and thereby increase AMP levels
and activation of AMPK, which promotes mitochondrial
biogenesis and healthy aging [18]. Furthermore, resveratrol
protects from metabolic damage and improve mitochondrial
respiration in a PGC-1α-dependent manner [19].
As we will see, several polyphenols improve endothelial
function by acting on mediators that are also described in
the hallmarks of aging, such as telomerase attrition and mito-
chondrial function.
1.5. Metabolism. Recent studies have shown cell communica-
tion pathways linked to diabetes mellitus and obesity and
how they may affect inflammatory and vascular health [20].
Therefore, a model to monitor endothelial dysfunction is
the induction of diabetes, which is widely associated with car-
diovascular diseases. Another measurable factor is obesity,
which increases the risk of insulin resistance, disrupts vascu-
lar homeostasis, and contributes to endothelial vasodilator
dysfunction and subsequent hypertension [21]. There is
compelling evidence that the polyphenols outlined in this
review can aid in weight loss and thereby decrease the risk
of vascular metabolic diseases. Thus, consumption of poly-
phenols to maintain a healthy weight could decrease the risk
of, and potentially even prevent, endothelial dysfunction
before symptoms arise. Moreover, evidence shows that res-
veratrol increases lipolysis not only in obese animals but also
in healthy, aged mice [22].
Based on this evidence, we propose in this review to study
the role of quercetin, catechin, resveratrol, and urolithin on the
endothelial dysfunction and related cardiovascular diseases.
2. Quercetin
Quercetin is a polyphenol belonging to the flavonoid family
with anti-inflammatory, antioxidant and possible senolytic
properties, among others [23–25]. It can be found in many
plant foods, such as onions, apples, and blueberries, as well
as in tea and red wine. Quercetin is not only beneficial in
diabetic or inflammatory conditions; it also induces reduc-
tion of fatty acid and triacylglycerol synthesis and inhibits
LDL oxidation in hepatocytes of healthy rats, thereby
promoting cardiovascular protective functions [26, 27].
In regard to the mechanisms of the control of endothelial
function, Akt, a downstream protein effector of PI3K, plays
an important role in improving vasodilatory actions of insu-
lin in human endothelium, thereby providing protective
effects [28]. In this context, quercetin increases Akt phos-
phorylation and subsequently eNOS phosphorylation and
NO production in response to insulin through inflammatory
pathways in diabetic rats [29]. Additionally, quercetin at con-
centrations of 50mg/kg exerts vasoprotective effects against
endothelial dysfunction induced by endoplasmic reticulum
stress. These effects are mediated by increased expression of
VEGF in streptozotozine-induced diabetic rats [30], which
is a model to study endothelial function.
ICAM-1 plays an essential role in inflammatory responses.
The TNF-α-induced expression of ICAM-1 was shown to be
reduced in an in vitro study with human endothelial cells
when treated with 10–50μM quercetin [31]. Another study
showed a significant inhibitory effect of 50μM treatment of
quercetin on VCAM-1, ICAM-1, and E-selectin expressions.
Inhibitory effects on COX-2 and iNOS protein levels were also
found when treated with concentrations of 5–50μM [32].
Quercetin has also been shown to activate the expression of
the protein HIF-1α, a key transcription factor in the induction
of the VEGF gene, as well as in regulating glucose and hypoxia
homeostasis, potentially through its antioxidative properties,
when treated with concentrations of 10mM [33].
Furthermore, quercetin has been shown to reduce body
weight gain in high-fat diet-fed mice by lowering serum lipid
levels and hepatic lipid accumulation. This is mediated
through the downregulation of cytochrome p450 2b genes,
which intervene in the synthesis of steroids, such as choles-
terol, and are therefore important in hepatic lipid homeostasis
[34, 35]. However, in this study, quercetin was administered in
0.3%w/w dosages to rats in order to examine quercetin’s effect
in hepatic lipid metabolism [34]. This dosage indicates that a
70kg individual would have to consume approximately 200
grams of quercetin supplements to achieve the same results.
Even though some studies have concluded that quercetin
might not be effective as a senolytic in endothelial cells, a
clinical trial conducted in 2019 showed that quercetin is
effective in decreasing senescent cells [25, 36]. However, as
this is the first direct evidence that senolytics are effective in
humans, further research is necessary to confirm the effects
of quercetin in regard to senescence.
These results show that quercetin exerts multiple health-
promoting effects through an increase in vascular endothelial
mediators, as well as possible weight loss, anti-aging, and
senolytic benefits.
3. Catechin
Catechin is a flavanol present in many plants and is especially
abundant in berries, cacao, and green tea [37]. A positive cor-
relation between green tea and cardiovascular health has
been found due to catechin’s antioxidant, anti-inflammatory,
antihypertensive, and antihyperlipidemic properties [38].
Catechin supplementation has been shown to signifi-
cantly increase flow-mediated dilation and significantly
reduce pulse wave velocity, diastolic blood pressure, and aug-
mentation index, which are parameters for cardiovascular
health in humans. This has been shown in several studies
3Oxidative Medicine and Cellular Longevity
performed in both young and elderly healthy individuals as
well as in individuals with cardiovascular disease risk
through the administration of pure catechin supplements in
quantities between 20 and 300mg/day and extracts from
foods rich in catechins, such as apples, grapes, and cacao in
quantities estimated between 7.5 and 146mg/day in a time
period ranging between 2 and 12 weeks [39, 40].
Furthermore, one study showed that even in exception-
ally low quantities, catechin exerted protective effects. The
intake of red grape polyphenol extract containing only
2.72mg catechin was shown to improve endothelial function
in patients with cardiovascular disease. In this study, 30 male
patients with coronary heart disease were randomly assigned
into two groups where one received polyphenol extract
dissolved in water, and a placebo group received water with-
out supplementation. The group consuming polyphenol
extract showed significant increased flow-mediated dilata-
tion compared to the placebo group, with a peak at 60min
after intake [41].
In addition to the cardiovascular and endothelial protective
effects of catechin, it has also been shown to reduce body fat.
Interventional studies of 3 daily cups of green tea after meals
showed an average metabolic boost of about one hundred calo-
ries a day by promoting lipidic oxidation [42]. A possible expla-
nation for why green tea consumption prolongs diet-induced
thermogenesis is catechin’s ability to inhibit catechol-O-methyl-
transferase, the enzyme that degrades norepinephrine [43].
However, in other studies, catechol-O-methyltransferase
was not shown to be suppressed after consumption of cat-
echin [44]. Therefore, a more plausible explanation for its
thermogenesis-promoting effects is through brown adipose
tissue signaling through evoking white adipocyte beiging
and suppression of adipogenesis [45].
Moreover, daily intake of catechin-comprised red wine
extract has shown to have a beneficial effect on aortic
expression of endothelial dysfunction biomarkers. These
include VCAM-1, ICAM-1, E-selectin, and LOX-1 as well
as proinflammatory cytokines such as TNF-α and IL-6 in
hyperhomocysteinemic mice [46]. Catechin also improves
redox imbalance and mitochondrial dysfunction, a promi-
nent feature of cardiovascular disease, by stimulating
phosphorylation of AMPK and ACC, inhibiting the key
enzymes of de novo lipogenesis, and blocking the TNF-α-
induced insulin signaling pathway [45, 47]. Furthermore, it
significantly induces PGC-1α, which in turn stimulates mito-
chondrial proliferation [48].
These results suggest that consumption of catechin-rich
food could be useful in combatting endothelial dysfunction
both through direct signaling pathways, as well as indirectly
through reducing risk factors of obesity-related metabolic
diseases, such as diabetes and cardiovascular disease.
4. Resveratrol
Resveratrol is one of the most studied plant secondary
metabolites [49]. Experimental studies have shown benefits
of resveratrol on the cardiovascular system through blockage
of low-density lipoprotein, cholesterol peroxidation, reduc-
tion of ROS, and prevention of platelet aggregation by
promoting vasodilation through NO synthesis and inhibition
of ET-1 [50–53].
In a randomized, double-blind, placebo-controlled study
on 24 hypertensive patients with endothelial dysfunction, a
single dose of 300mg of resveratrol supplement was shown
to increase branchial flow-mediated dilation response and
thereby improve endothelial function [54]. In a similar study,
resveratrol improved flow-mediated dilation of the brachial
artery of 19 overweight men and women with hypertension in
a dose-dependent manner, with an increase from 4:1 ± 0:8%
measured in the placebo group to 7:7 ± 1:5% after the intake
of 270mg resveratrol 3 times weekly [55].
Studies in vitro further confirm the beneficial effects of
resveratrol on endothelial metabolism and inflammation. In
a study with TNF-α-activated endothelial cells, the polyphe-
nol intervention of 5-20μM significantly reduced the levels
of VEGF, ROS, and proinflammatory mediator such as IL-8
and ICAM-1 [53].
PPARδ, which has been shown to have increased activity
in endothelial cells after resveratrol consumption in dosages
of 20mg/kg/day over a two-week span, contributes to the
beneficial effect of SIRT1 to ameliorate endothelial dysfunc-
tion in diabetic and obese mice [56].
Additionally, PPARδ activation by synthetic ligands pro-
tects against obesity, decreases triglyceride levels, increases
HDL-cholesterol, and improves insulin sensitivity and could
therefore also be helpful in regard to weight loss [57, 58].
150mg/day of resveratrol intake in 11 obese individuals over
30 days in a randomized double-blind crossover study
resulted in metabolic changes mimicking the effects of calorie
restriction [59]. These changes included reduced systolic
blood pressure, adipose tissue lipolysis, plasma fatty acid,
and glycerol levels and increased expression of AMPK,
SIRT1, and PGC-1α protein levels.
Increased expression of AMPKα by resveratrol treatment
has also been found to be effective in elderly mice. In a study
where 12 healthy, elderly mice were supplemented with
2.3μg/kg/day of resveratrol for two consecutive days, fatty
acid mobilization and degradation increased, and their syn-
thesis was inhibited [22].
From this, we can conclude that resveratrol consumption
can aid in weight loss and aging, prevent metabolic diseases
before they arise, and improve endothelial metabolism in those
with inflammatory states and cardiovascular-related diseases.
5. Urolithin
Urolithins are the major metabolites of dietary ellagic acid,
found in the form of ellagitannin in foods such as walnuts,
strawberries, and pomegranate. The three most abundant
bioavailable ellagitannin metabolites are urolithins A, B,
and C, which are transformed by the gut bacteria Gordoni-
bacter urolithinfaciens and Gordonibacter pamelaeae [60].
Numerous studies indicate that apart from their anti-
inflammatory effects, urolithin exhibits antiatherosclerotic
and anticarcinogenic effects, which support their potential
preventive effect against cardiovascular diseases [61, 62].
One of the mechanisms by which quercetin acts is
through inhibiting iNOS production and decreasing the
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expression of the proinflammatory cytokines IL-1β, TNF-α,
and IL-6 [63, 64].
A double-blind randomized controlled crossover human
intervention trial with 10 healthy males confirmed that ella-
gitannins acutely improve endothelial function through
increasing flow-mediated dilation after the consumption of
red raspberries in 200 and 400 g quantities when compared
to a placebo group [65]. In another study where human
artery endothelial cells were incubated with 50μg/mL ox-
LDL, urolithin A improved the productions of NO and eNOS
in a dose-dependent manner [66]. Additionally, it signifi-
cantly suppressed expressions of TNF-α, IL-6, ICAM-1,
MCP-1, and ET-1 and increased PPAR-γ mRNA levels
[66]. The beneficial effects attributed to the consumption of
ellagitannin-containing foods against cardiovascular diseases
were confirmed in another study where human aortic
endothelial cells were exposed to TNF-α and treatment with
Uro-A glucuronide inhibited monocyte adhesion and endo-
thelial cell migration and decreased the expression of CCL-2
and IL-8 [61].
In vivo animal studies have shown that treatment with
ellagic acid extracted from raspberry seed flour in concentra-
tions estimated to 0.03% of the total diet lowers the elevated
triglyceride and LDL cholesterol levels and oxidative stress
provoked by a high-fat high-sucrose diet [67]. Another study
showed that treatment of 7.5 and 15mg/kg for 10 days
reduced LDL, free fatty acids, triglyceride levels, and lipid
peroxidation, while exerting cardiac protective effects by
reducing ventricular hypertrophy and arrhythmia in myo-
cardial infarction-induced rats [68].
In regard to obesity, urolithin A has been shown to
reduce triglyceride accumulation, lipogenesis and gene
expression related to adipocyte formation such as adiponec-
tin, GLUT4, and FABP4 in 3T3-L1 adipocytes [69].
These results suggest that urolithin A has protective ben-
efits against inflammation states and metabolic-related dis-
eases, such as diabetes and obesity, which in turn are risk
factors for cardiovascular disease and endothelial
dysfunction.
The following table presents the mechanisms through
which each of the four outlined polyphenols exert their pro-
tective effects as found through studies on humans, animals,
and in vitro (Table 1).
6. Discussion
The exerted effects of catechin, quercetin, urolithin, and res-
veratrol on endothelial function are beneficial not only for
patients with cardiovascular disease, diabetes, or endothelial
dysfunction but also for all healthy individuals as it can
improve the effects of aging on the endothelia and aid in
weight loss, thereby further improving health status while
lowering the risk of several diseases, including those caused
by endothelial dysfunction.
In 2016, an article was published outlining the relation
between a lower incidence of cardiovascular disease and the
ingestion of antioxidants performed on 800 individuals in
Holland. This effect was attributed to the consumption of fla-
vonoids present in the diet, such as in apples, onion, and tea.
Although the exact compounds responsible for this effect
were not determined, the authors described quercetin as
one of them, as it was the compound with the highest antiox-
idant effect, due to its molecular structure [23]. Previous
in vitro studies performed with human endothelial cells show
that quercetin exerts not only antioxidant effects but also
anti-inflammatory and vasodilator effects though downregu-
lation of ACE [24]. Additionally, in these same cells, the anti-
inflammatory effects of quercetin mediated by a decrease in
I-CAM, NF-κB, and AP-1 have been discovered [31, 32].
Furthermore, studies in vitro performed on rat liver cells
have shown that quercetin diminishes the synthesis of fatty
acids and triglycerides [26]. These data could explain the
decrease in cardiovascular disease risk in the studies previ-
ously cited. However, the concentrations used in the studies
in vitro are of micromolar magnitudes, which cannot be
reached through diet and can only be achieved through sup-
plementations. Toxicity studies have been performed in
humans, where it has been stated that concentrations up to
1 g/day of quercetin does not pose any harm. Should one sur-
pass this concentration however, quercetin could become
prooxidant and thereby exert genotoxic effects [70].
The studies on the benefits of catechin also showed
enhancements of the cardiovascular system through antioxi-
dant, anti-inflammatory, antiproliferative, antithrombogenic,
and antihyperlipidemic mechanisms [38]. The studies per-
formed on humans with catechin and epigallocatechin supple-
ments vary in dosages between 20 and 300mg/day, with
variations in duration between 2 and 6 weeks, where increased
flow-mediated dilation was found. These findings, along with
those previously described, confirm that the consumption of
catechin favors cardiovascular health [39]. Additionally, die-
tary intake of catechin through tea, grapes, or cacao has been
proven to favor the increase in flow-mediated dilation in con-
centrations estimated to 146mg from cacao and 7.5mg from
grapes. However, as these aliments contain a multitude of
polyphenols, the suggested mechanisms on the cardiovascular
system could be affected by other compounds. It is important
to note that the outlined benefits were seen both in patients
with cardiovascular diseases and obese individuals, as well as
in young and elderly individuals [39–41, 44]. Concerning dos-
age, there have been no reported findings of toxicity from cat-
echin, although it is possible that it could follow the same
guidelines as quercetin.
Resveratrol is one of the most studied polyphenols. It can
be absorbed quickly due to its lipophilic characteristics and
even more so when ingested with foods rich in fats or with
alcohol such as red wine. However, it is quickly metabolized
in the liver and therefore, its distribution is highly variable
[71]. As shown in this review, resveratrol clearly improves
lipidic profiles and endothelial smooth muscle relaxations
in hypertense and obese patients [54, 55]. In animal studies,
it has been shown how this polyphenol increases lipid catab-
olism in skeletal muscle, which could possibly explain the
changes in lipidic profiles in humans [71]. Moreover, studies
have shown the protective effects of resveratrol in ischemic
reperfusion-induced rats, mediated by autophagia and the
mTOR signaling pathway [51]. In endothelial cells, resvera-
trol has been shown to decrease TNF-α levels and thereby
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prevent inflammation [53], as well as protect against lipidic
peroxidation in human monocytes [52]. Based on these
findings, we can conclude that the authors of these studies
agree that resveratrol exerts beneficial effects on the cardio-
vascular system.
Human studies relating urolithin to endothelial function
are scarce. However, in one study performed on healthy indi-
viduals where 200-400 g of raspberry drink was administered,
the presence of ellagitannins, the precursors of urolithin, was
found present in the blood, in nanomolar magnitudes, with
an augmented capacity for flow-mediated dilation [65],
results similar to those found in quercetin. It is important
to note that the exerted effects were likely not exclusively
caused by urolithin, as the drink was rich in polyphenolic
compounds. Interestingly, in the study performed on myo-
cardial infarction-induced rats, although urolithin was found
to exert protective benefits on the cardiovascular system,
there was no significant difference between the groups
administered 7.5 and 15mg/day, suggesting a saturation of
the protective effects at the lower dosage. Moreover, in the
control groups, there was no significant difference found in
the lipidic profile in the nonsupplemented healthy animals
and the healthy animals administered urolithin, suggesting
that these dosages are not beneficial in healthy animals
Table 1: Outlined effects of quercetin, catechin, resveratrol, and urolithin studied in vitro, in animals, and in humans.
Molecule Study type Mechanisms Refs.
Quercetin
In vitro
Reduces TNF-α-induced expression of ICAM-1
Inhibits VCAM-1 and E-selectin expression, as well as
COX-2 and iNOS






Induces reduction of fatty acid and triacylglycerol synthesis and
inhibits LDL oxidation
Increases Akt phosphorylation, eNOS phosphorylation,
and NO production
Increases expression of VEGF






Human Reduces cellular senescence [25]
Catechin
In vitro
Improves redox imbalance and mitochondrial dysfunction
by AMPK and ACC phosphorylation





Exerts beneficial effects on aortic expression of endothelial dysfunction
biomarkers (VCAM-1, ICAM-1, E-selectin, LOX-1, TNF-α, and IL-6)
[46]
Human
Increases flow-mediated dilation, reduces pulse wave velocity and
diastolic blood pressure






Reduces cholesterol peroxidation, reactive oxygen species levels, and platelet
aggregation by promoting vasodilation through NO synthesis and inhibition
of endothelin-1





Ameliorates endothelial dysfunction through PPARδ and
SIRT1 activation
Increases expression of AMPKα, activates fatty acid mobilization and degradation,




Increases branchial flow-mediated dilation response





Inhibits monocyte adhesion, endothelial cell migration, and CCL-2 and
IL-8 expressions
Inhibits iNOS and decreases proinflammatory cytokines expression
(IL-1β, TNF-α, and IL-6)
Improves NO production and eNOS activity in a dose-dependent manner and
suppresses the expression of TNF-α, IL-6, ICAM-1, MCP-1, and endothelin 1





Reduces LDL cholesterol, triglycerides, free fatty acids, and oxidative stress
Reduces ventricular hypertrophy and arrhythmia
[67, 68]
[68]
Human Improves endothelial function through improvements in flow-mediated dilation [65]
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[68]. Another study performed on animals administered a
diet high in fats and sugar supplemented with 100mg of
raspberry extract showed an improvement in lipidic profile
and parameters of inflammation and oxidative stress [67].
It would be interesting to confirm these results with their
concrete mechanisms and signaling pathways. The in vitro
studies outlined in this review confirm some of these param-
eters. It has been shown how 5-15μM of urolithin exerts
anti-inflammatory effects on endothelial cells [61]. Addition-
ally, with these same concentrations, an anti-inflammatory
pathway through activation of macrophages with lipopoly-
saccharides has been confirmed [63, 64]. Other action mech-
anisms suggest a signaling pathway through microRNA-27
and ERK/PPAR-γ in endothelial dysfunction caused by oxi-
dized cholesterol treated with 5μM [66]. It is important to
note that the concentrations of urolithin in the previously
cited human study are administered in nanomolar magni-
tudes and it could therefore be interesting to perform studies
in vitro to verify if the effects of these nutritionally relevant
concentrations are beneficial.
The conditions in which polyphenols are consumed
should also be taken into consideration; as for both quercetin
and resveratrol, marked differences in functional effects were
observed dependent on standard or high-fat dietary back-
grounds [72]. As mentioned, it is important to note that the
majority of the studies mentioned in this review were per-
formed with polyphenols in supplemental quantities, rather
than from natural plant sources, making the dosage recom-
mendations for humans difficult to determine. Some of the
amounts used in these trials may not be nutritionally rele-
vant, and although no toxicity has been found in the articles
outlined in this review when administered for up to 3
months, the extrapolation of the concentrations adminis-
tered in some animal studies could prove to cause acute tox-
icity in humans. Further studies should be conducted with
these polyphenols in quantities possible to achieve through
diet. It would also be interesting to study these four
polyphenols simultaneously, to see if they act upon common
signaling pathways, if they have synergic effects, or if the ben-
eficial effects could be increased when working together.
7. Conclusion
Thus, we can conclude that the polyphenols quercetin,
catechin, resveratrol, and urolithin could be an effective tool,
as they could serve as pharmacologic targets in treatments
for diseases related to the cardiovascular system. These
polyphenols can be used in combination with pharmacolog-
ical treatments such as anti-inflammatory, anticoagulant,
and antihypertensive drugs, to improve the damage caused
by endothelial dysfunction (Figure 2). Additionally, they
can exert protective effects in healthy individuals to reduce
the risk of cardiovascular diseases.
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Pro-inflammatory molecules: TNF-𝛼, ICAM-1, VCAM-1,
E-selectin, LOX-1, IL-6, IL-8…
(ii)
(i) Anti-oxidant molecules: HIF-1a, PGC-1a, SIRT1…
Direct antioxidant properties of polyphenols
Activate lipolysis and inhibit lipogenesis
Less cholesterol and triglycerides, increase HDL
Cytochrome P450 downregulation and PPAR 𝛿 activation
Figure 2: The effects of polyphenols in the Mediterranean diet on pathologies related to endothelial dysfunction.
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VEGF: Vascular endothelial growth factor
vWF: von Willebrand factor.
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